Analysis of factors influencing the determination of indications for allergen-specific immunotherapy

Main Article Content

Bo Ding
Shiwen Gao
Jun Huang
Songdi Gong
Jiahui Lin
Guoliang Ding
Qiuzhi Shen
Wentao Wang
Mei Yang
Hui Wang
Chunmei Shen
Yanming Lu

Keywords

allergen-specific immunotherapy, rhinitis, asthma, dermatitis, guidelines

Abstract

Objective: To develop a questionnaire and a scoring system for evaluating physicians’ knowledge of allergen immunotherapy (AIT).


Methods: Questionnaire was designed using the Questionnaire Star tool. A total of 1024 physicians were assessed, and based on the score divided into accurate judgment and inaccurate judgment groups. Statistical analysis was done, and counting data were expressed as frequencies and percentage values. Chi-square test and multi-factor logistic analysis were used to determine influencing factors on the indications for AIT.


Results: Physician’s age, grade of the hospital, and pediatric specialty influenced the accurate judgment of AIT indication after adjustment for independent variables (P < 0.05). In all, 80.5% physicians exercised accurate assessment for allergic rhinitis. Allergic conjunctivitis was judged accurately by 47.0% physicians. Bronchial asthma was judged accurately by 71.0% physicians, and atopic dermatitis by 61.3% physicians, with a higher accuracy rate for pediatricians than nonpediatricians for all the mentioned conditions (P < 0.05). There was no significant difference in the accuracy of judgment between pediatricians and non-pediatricians in terms of AIT for food allergy and dust mite sensitization (P > 0.05).


Conclusion: The results of our study demonstrated a high accuracy judgment rate among clinicians for rhinitis, asthma, and dermatitis, and a low accuracy rate for desensitization of healthy people with allergic conjunctivitis, food allergies, and allergen sensitization.

Abstract 132 | PDF Downloads 160 HTML Downloads 36 XML Downloads 3

References

1. Halken S, Larenas-Linnemann D, Roberts G, Calderón MA, Angier E, Pfaar O, et al. EAACI guidelines on allergen immunotherapy: Prevention of allergy. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. 2017;28:728–45. 10.1111/pai.12807.

2. Yang Y, Zeng L, Zhou W, Han T. Factors influencing allergy process early in life. Chin J Allergy Clin Immunol. 2022;16:84–9.

3. Asthma Group, Respiratory Branch of Chinese Medical Association. Guidelines for prevention and treatment of bronchial asthma (2020 edition). Chin J Tuberc Respir Dis. 2020;43:1023–48.

4. Rhinology Group of Editorial Board of Chinese Journal of Otolaryngology Head and Neck Surgery Rhinology Group, Chinese Medical Association Otolaryngology Head and Neck Surgery Branch. Guidelines for the diagnosis and treatment of allergic rhinitis in China (2022, revised edition). Chin J Otorhinolaryngol Head Neck Surg. 2022;57:106–29.

5. Tat TS. Adherence to subcutaneous allergen immunotherapy in southeast Turkey: A real-life study. Med Sci Monit Int Med J Exp Clin Res. 2018;24:8977–83. 10.12659/MSM.910860.

6. Larsen JN, Broge L, Jacobi H. Allergy immunotherapy: the future of allergy treatment. Drug Discov Today. 2016;21:26–37. 10.1016/j.drudis.2015.07.010.

7. Tesch F, Sydendal Grand T, Wuestenberg E, Elliott L, Schmitt J, Kuster D. Healthcare costs associated with allergic rhinitis, asthma allergy immunotherapy. Eur Ann Allergy Clin Immunol. 2020;52:164–74. 10.23822/EurAnnACI.1764-1489.126.

8. Yang L, Zhu R. Immunotherapy of house dust mite allergy. Hum Vaccines Immunother. 2017;13:2390–6. 10.1080/21645515.2017.1364823.

9. Nam Y-H, Lee S-K. Physician’s recommendation and explanation is important in the initiation and maintenance of allergen immunotherapy. Patient Prefer Adher. 2017;11:381–7. 10.2147/PPA.S118368.

10. Drazdauskaitė G, Layhadi JA, Shamji MH. Mechanisms of allergen immunotherapy in allergic rhinitis. Curr Allergy Asthma Rep. 2020;21:2. 10.1007/s11882-020-00977-7.

11. Paiva Ferreira LKD, Paiva Ferreira LAM, Monteiro TM, Bezerra GC, Bernardo LR, Piuvezam MR. Combined allergic rhinitis and asthma syndrome (CARAS). Int Immunopharmacol 2019;74: 105718. 10.1016/j.intimp.2019.105718.

12. Reid EF, Krishna MT, Bethune C. Allergy teaching is suboptimal and heterogeneous in the undergraduate medical curriculum in the UK. J Clin Pathol. 2019;72:221–4. 10.1136/jclinpath-2017-204885.

13. Işık S, Çağlar A, Eroğlu-Filibeli B, Çağlayan-Sözmen Ş, Arıkan-Ayyıldız Z, Asilsoy S, et al. Knowledge, perspectives and attitudes about allergen-specific immunotherapy for respiratory allergic disease among pediatricians in Turkey. Allergol Immunopathol (Madr). 2017;45:193–7. 10.1016/j.aller.2016.07.004.

14. Pajno GB, Fernandez-Rivas M, Arasi S, Roberts G, Akdis CA, Alvaro-Lozano M, et al. EAACI guidelines on allergen immuno-therapy: IgE-mediated food allergy. Allergy 2018;73:799–815. 10.1111/all.13319.

15. Gao X, Xu L, Qu Z. Construction of health education system in children with allergic diseases. Chin J Appl Clin Pediatr. 2021:467–70.

16. Xiang L, Zhao J, Bao Y, Shao J, Liu C, Li M, et al. Expert con-Expert consensus on mite-specific immunotherapy for airway allergic diseases in children. Chin J Appl Clin Pediatr. 2018;33:1215–23.